NCT04653350

Brief Summary

in Pakistan 9.9 million people are osteoporotic and 7.2 million amongst them are women. Globally after every 3 seconds there is occurrence of fragility fracture.In Pakistan females carries different risk factors based on distinct culture, environment, diet and lifestyle. So there is dire need to conduct more high quality clinical trials at National level in order to establish strong evidence in favor of low cost but highly effective exercise protocols for such a significant public health issue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

November 26, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 4, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

June 21, 2022

Status Verified

June 1, 2022

Enrollment Period

1.6 years

First QC Date

November 26, 2020

Last Update Submit

June 17, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Femoral Neck BMD (FN BMD)

    Change from Baseline in Femoral Neck Bone Mineral Density measured by DEXA scan

    8 Months

  • Lumbar Spine BMD (LS BMD)

    Change from Baseline in Lumbar Spine Bone Mineral Density measured by DEXA scan

    8 Months

Secondary Outcomes (16)

  • 1 RM for Leg Extensors

    3 Months

  • 1 RM for Leg Extensors

    6 Months

  • 1 RM for Trunk Extensors

    3 Months

  • 1 RM for Trunk Extensors

    6 Months

  • 30-second sit to stand test (Reps)

    3 Months

  • +11 more secondary outcomes

Study Arms (2)

HIT-MMEX Group

EXPERIMENTAL

In this group Supervised High intensity Progressive Resistance Training, High intensity weightbearing/Impact exercises and High challenging Balance Training will be given. 2 times/week for 40-50minutes session progressively over the duration of 8 months.

Other: High Intensity Exercises

Control Group

ACTIVE COMPARATOR

In this Group Supervised general fitness exercises including general body stretches, treadmill walking, mild to moderate intensity progressive resistance training \& balance exercises will be given. 2 times/week for 40-50minutes session progressively over the duration of 8 months.

Other: General Exercises

Interventions

Supervised High intensity Progressive Resistance Training, High intensity weightbearing/Impact exercises and High challenging Balance Training will be given. 2 times/week for 40-50minutes session progressively over the duration of 8 months.

HIT-MMEX Group

Supervised general fitness exercises including general body stretches, treadmill walking, mild to moderate intensity progressive resistance training \& balance exercises will be given. 2 times/week for 40-50minutes session progressively over the duration of 8 months

Control Group

Eligibility Criteria

Age45 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal Women, at least 3 years since last mensuration.
  • Age: 45-70years
  • Body mass index (BMI) \<30kg/m2
  • Community ambulant without walking aid
  • Good general health
  • Willing for exercise therapy

You may not qualify if:

  • History of fragility fracture in addition to BMD T-score of -2.5 or less
  • MMSE \< 20
  • Taking Hormone replacement therapy or steroids from last 1 year.
  • Had participated in regular exercise for last 1 year
  • Systemic illness: hyperthyroidism, hyperparathyroidism, Diabetes Mellitus, renal failure, any malignancy, extensive radiation exposure
  • Any orthopedic injury/disorder hindering performance of exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Rehab Center RCRAHS Potohar campus

Rawalpindi, Punjab Province, 40100, Pakistan

Location

Behbud Association of Pakistan

Rawalpindi, Punjab Province, 46000, Pakistan

Location

Related Publications (7)

  • Gianoudis J, Bailey CA, Sanders KM, Nowson CA, Hill K, Ebeling PR, Daly RM. Osteo-cise: strong bones for life: protocol for a community-based randomised controlled trial of a multi-modal exercise and osteoporosis education program for older adults at risk of falls and fractures. BMC Musculoskelet Disord. 2012 May 28;13:78. doi: 10.1186/1471-2474-13-78.

    PMID: 22640372BACKGROUND
  • Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. J Bone Miner Res. 2018 Feb;33(2):211-220. doi: 10.1002/jbmr.3284. Epub 2017 Oct 4.

    PMID: 28975661BACKGROUND
  • Watson S, Weeks B, Weis L, Harding A, Horan S, Beck B. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. J Bone Miner Res. 2019 Mar;34(3):572. doi: 10.1002/jbmr.3659. Epub 2019 Feb 25. No abstract available.

    PMID: 30861219BACKGROUND
  • Watson SL, Weeks BK, Weis LJ, Horan SA, Beck BR. Heavy resistance training is safe and improves bone, function, and stature in postmenopausal women with low to very low bone mass: novel early findings from the LIFTMOR trial. Osteoporos Int. 2015 Dec;26(12):2889-94. doi: 10.1007/s00198-015-3263-2. Epub 2015 Aug 5.

    PMID: 26243363BACKGROUND
  • Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. High-intensity exercise did not cause vertebral fractures and improves thoracic kyphosis in postmenopausal women with low to very low bone mass: the LIFTMOR trial. Osteoporos Int. 2019 May;30(5):957-964. doi: 10.1007/s00198-018-04829-z. Epub 2019 Jan 5.

    PMID: 30612163BACKGROUND
  • Marques EA, Mota J, Machado L, Sousa F, Coelho M, Moreira P, Carvalho J. Multicomponent training program with weight-bearing exercises elicits favorable bone density, muscle strength, and balance adaptations in older women. Calcif Tissue Int. 2011 Feb;88(2):117-29. doi: 10.1007/s00223-010-9437-1. Epub 2010 Nov 27.

    PMID: 21113584BACKGROUND
  • Riaz H, Babur MN, Farooq A. Effects of high-intensity multi-modal exercise training (HIT-MMEX) on bone mineral density and muscle performance in postmenopausal women. A Pilot randomized controlled trial. J Pak Med Assoc. 2022 Oct;72(10):1904-1908. doi: 10.47391/JPMA.5394.

MeSH Terms

Conditions

Osteoporosis, Postmenopausal

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

OsteoporosisBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Huma Riaz, Phd*

    Riphah International University

    PRINCIPAL INVESTIGATOR
  • Muhammad Naveed Babur, Phd

    Isra University islamabad

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Females participating in a clinical trial will be kept blind with respect to their allocated exercise group. The assessor doing reporting for the DEXA scan will also be kept blind about the patient group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This will be a Single factor, Pretest-Postest Control group Design with parallel assignment of patients into two groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 26, 2020

First Posted

December 4, 2020

Study Start

November 1, 2020

Primary Completion

June 10, 2022

Study Completion

June 10, 2022

Last Updated

June 21, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations